Literature DB >> 32091183

Clinical features, molecular results, and management of 12 individuals with the rare arthrochalasia Ehlers-Danlos syndrome.

Sandy Ayoub1, Neeti Ghali1, Chloe Angwin1, Duncan Baker2, Stella Baffini3, Angela F Brady1, Maria Luisa Giovannucci Uzielli3, Cecilia Giunta4, Diana S Johnson5, Tomoki Kosho6, Katherine Neas7, F Michael Pope1, Frank Rutsch8, Gloria Scarselli3, Glenda Sobey5, Anthony Vandersteen9, Fleur S van Dijk1.   

Abstract

Arthrochalasia Ehlers-Danlos syndrome (aEDS) is a rare autosomal dominant connective tissue disorder that is characterized by congenital bilateral hip dislocations, severe generalized joint hypermobility, recurrent joint (sub)luxations, and skin hyperextensibility. To date, 42 patients with aEDS have been published. We report 12 patients with aEDS from 10 families with 6 unpublished individuals and follow-up data on 6 adult patients. The clinical features are largely comparable with patients reported in the literature. Most (n = 10) patients had variants leading to (partial) loss of exon 6 of the COL1A1 or COL1A2 genes. One patient did not have a previously reported likely pathogenic COL1A1 variant. Data regarding management were retrieved. Hip surgery was performed in 5/12 patients and 3/12 patients underwent spinal surgery. As much as 4/12 patients were wheelchair-bound or unable to walk unaided. Fractures were present in 9/12 individuals with 1 patient requiring bisphosphonate treatment. Echocardiograms were performed in 10 patients and 2 individuals showed an abnormality likely unrelated to aEDS. One patient gave birth to two affected children and went through preterm labor requiring medication but had no additional complications. Of the eight adults in our cohort, the majority entered a career. Our data point toward a genotype-phenotype relationship with individuals with aEDS due to pathogenic COL1A1 variants causing complete or partial loss of exon 6 being more severely affected regarding musculoskeletal features. There is a significant lack of knowledge with regard to management of aEDS, particularly in adulthood. As such, systematic follow-up and multidisciplinary treatment is essential.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990COL1A1; zzm321990COL1A2; Ehlers-Danlos syndrome (EDS); arthrochalasia EDS; congenital hip dislocation

Mesh:

Substances:

Year:  2020        PMID: 32091183     DOI: 10.1002/ajmg.a.61523

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

Review 1.  Mechanobiology in the Comorbidities of Ehlers Danlos Syndrome.

Authors:  Shaina P Royer; Sangyoon J Han
Journal:  Front Cell Dev Biol       Date:  2022-04-25

Review 2.  The Ehlers-Danlos Syndromes against the Backdrop of Inborn Errors of Metabolism.

Authors:  Tim Van Damme; Marlies Colman; Delfien Syx; Fransiska Malfait
Journal:  Genes (Basel)       Date:  2022-01-29       Impact factor: 4.096

Review 3.  Ehlers-Danlos Syndrome Type Arthrochalasia: A Systematic Review.

Authors:  Marta Martín-Martín; Jonathan Cortés-Martín; Maria Isabel Tovar-Gálvez; Juan Carlos Sánchez-García; Lourdes Díaz-Rodríguez; Raquel Rodríguez-Blanque
Journal:  Int J Environ Res Public Health       Date:  2022-02-07       Impact factor: 3.390

Review 4.  Ehlers-Danlos syndromes and their manifestations in the visual system.

Authors:  Samuel Asanad; May Bayomi; Douglas Brown; Joshua Buzzard; Eric Lai; Carlthan Ling; Trisha Miglani; Taariq Mohammed; Joby Tsai; Olivia Uddin; Eric Singman
Journal:  Front Med (Lausanne)       Date:  2022-09-27

5.  Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.

Authors:  Marco Ritelli; Marina Venturini; Valeria Cinquina; Nicola Chiarelli; Marina Colombi
Journal:  Orphanet J Rare Dis       Date:  2020-07-31       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.